New Delhi: Biotech product data platform SUJVIKA AI Portal, developed in collaboration with industry partner Association of Biotechnology Led Enterprises (ABLE), has been launched to provide structured and authenticated data on biotechnology product imports to support research, industry planning and domestic biomanufacturing efforts.
The portal was launched by Union Minister Dr Jitendra Singh on the 40th Foundation Day of the Department of Biotechnology (DBT). This launch underscores India’s push to strengthen its biotechnology ecosystem and accelerate progress toward a $1 trillion bioeconomy by 2047.
Addressing the gathering, Dr Jitendra Singh said biotechnology will power the next industrial revolution and that India is steadily moving towards building a $1 trillion bioeconomy by 2047 under the vision of Viksit Bharat.
He emphasised that India has ensured it will not remain a late entrant in emerging technologies and has positioned biotechnology as a key driver of future economic growth, with initiatives such as SUJVIKA playing a catalytic role.
SUJVIKA: AI-Driven Trade Intelligence Platform for Biotech Sector
SUJVIKA is a Trade Statistics Digital Intelligence Platform that presents authenticated biotechnology product import data in a structured and accessible format.
The portal offers sector-wise insights into biochemical products, industrial enzymes and other biotechnology imports.
Through SUJVIKA, researchers, startups and industry stakeholders can identify high-value and high-volume imports, assess import dependency and prioritise indigenisation and R&D efforts.
The platform is designed to support evidence-based planning and promote public–private partnerships for strengthening domestic biomanufacturing capabilities.
Also Read: IIT Delhi Hosts Launch of BFI Innovation Full Stack with 15+ Medical Partners
DBT at 40: Bioeconomy Grows 16-Fold to $165.7 Billion
Congratulating the DBT fraternity on completing four decades since its establishment in 1986, Dr Jitendra Singh said the Department has evolved into a premier organisation nurturing startups, strengthening academia–industry partnerships, building scientific infrastructure and enabling innovation for societal use.
He noted that India had fewer than 100 biotech startups in 2014, while the number has now crossed 11,000. During the same period, India’s bioeconomy has expanded from nearly USD 10 billion in 2014 to about USD 165.7 billion in 2024, marking a 16-fold growth.
The Minister said India is now ranked among the top biotech destinations globally and stands as one of the leading vaccine manufacturers in the world, with SUJVIKA expected to further reinforce domestic capabilities.
BioE3 Policy and High-Performance Biomanufacturing
Referring to policy reforms, Dr Jitendra Singh stated that under the leadership of Prime Minister Shri Narendra Modi, biotechnology has emerged as a central pillar of India’s development strategy.
He recalled that the Union Cabinet approved the integrated BioE3 Policy – Biotechnology for Economy, Environment and Employment – to foster high-performance biomanufacturing across the country.
DBT, Biotechnology Industry Research Assistance Council (BIRAC) and the Biotechnology Research and Innovation Council (BRIC) are implementing the policy to strengthen indigenous capabilities and expand India’s bioindustrial base. The Minister noted that digital platforms such as SUJVIKA complement the BioE3 framework by providing actionable trade intelligence.
Also Read: Startup India Fund of Funds 2.0 to Support Deep Tech and Early-Growth Startups
National Biofoundry Network and ₹2,000 Crore RDI Call
Dr Jitendra Singh highlighted the establishment of the National Biofoundry Network comprising six specialised biofoundries and 21 advanced bio-enabler facilities to accelerate scale-up and commercialisation.
He also referred to a network of 95 bio-incubators across 21 States and UTs, four regional mentoring centres and technology transfer offices supporting more than 1,800 incubatees.
The Minister said the first national call of ₹2,000 crore under the ₹1 lakh crore Research, Development and Innovation (RDI) initiative will further strengthen the biotech sector and support enterprises ready for large-scale growth. He added that initiatives like SUJVIKA will help enterprises make informed strategic decisions.
Expanding Frontiers: Space Biotech and Genomics
The Minister said India has entered new domains such as space biotechnology and space medicine through an MoU between DBT and the Indian Space Research Organisation (ISRO)/Department of Space.
He also referred to the GenomeIndia Project, under which whole genome sequencing data of 10,000 individuals from 99 diverse populations has been made available through the Indian Biological Data Centre.
According to the Minister, this will enable future development of personalised therapies and strengthen India’s genomic research capabilities.
Dr Jitendra Singh further mentioned India’s first human gene therapy trial for Severe Hemophilia A, supported through DBT and BIRAC, which achieved sustained Factor VIII production and reduced dependence on repeated infusions.
He stressed that integration of biotechnology with digital tools, including artificial intelligence – as demonstrated through SUJVIKA – will significantly enhance research efficiency and precision in gene sequencing, diagnostics and drug discovery.
